Climb Bio, Inc. (CLYM)
10.78
-0.16
(-1.46%)
USD |
NASDAQ |
Oct 05, 09:55
Climb Bio Net Income (Quarterly) : -13.50M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.50M |
| March 31, 2026 | -13.72M |
| December 31, 2025 | -17.52M |
| September 30, 2025 | -12.89M |
| June 30, 2025 | -8.666M |
| March 31, 2025 | -20.78M |
| December 31, 2024 | -8.416M |
| September 30, 2024 | -8.895M |
| June 30, 2024 | -54.89M |
| March 31, 2024 | -1.697M |
| December 31, 2023 | -3.641M |
| September 30, 2023 | -3.968M |
| June 30, 2023 | -5.22M |
| Date | Value |
|---|---|
| March 31, 2023 | -22.29M |
| December 31, 2022 | -7.762M |
| September 30, 2022 | -9.682M |
| June 30, 2022 | -14.60M |
| March 31, 2022 | -13.20M |
| December 31, 2021 | -10.54M |
| September 30, 2021 | -9.615M |
| June 30, 2021 | -8.719M |
| March 31, 2021 | -18.60M |
| September 30, 2020 | -2.258M |
| June 30, 2020 | -1.631M |
| March 31, 2020 | -1.916M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -1.755M |
| Cullinan Therapeutics, Inc. | -53.70M |
| Q32 Bio, Inc. | -8.946M |
| Artiva Biotherapeutics, Inc. | -25.00M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 13.50M |
| EPS Diluted (Quarterly) | -0.1772 |
| Enterprise Value | 446.54M |
| Earnings Yield | -7.68% |
| Normalized Earnings Yield | -7.680 |